Previous Close | 6.63 |
Open | 6.40 |
Bid | 6.55 x 1300 |
Ask | 6.68 x 900 |
Day's Range | 6.37 - 6.82 |
52 Week Range | 2.87 - 8.58 |
Volume | |
Avg. Volume | 3,786,280 |
Market Cap | 684.438M |
Beta (5Y Monthly) | 0.98 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -10.43 |
Earnings Date | Mar 02, 2023 - Mar 06, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.33 |
Subscribe to Yahoo Finance Plus to view Fair Value for BLUE
The chief executive of bluebird bio's oncology-focused spinout believes that this year, it will take off as a company in its own right.
Every investor in bluebird bio, Inc. ( NASDAQ:BLUE ) should be aware of the most powerful shareholder groups. And the...
bluebird bio, Pros Holdings and Norwegian Cruise Line are part of the Zacks Screen of the Week article.